US/Italy: Cyberonics, Italy’s Sorin merge to create medical technology leader
Sorin a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics a medical device company with core expertise in neuromodulation, announced on Thursday their merger plan to create a new global leader in medical technologies with a combined equity value of approximately $2.7 billion.
Featured News
US Appeals Court Reinstates AI Pricing Antitrust Case Against Atlantic City Casinos
Jul 29, 2026 by
CPI
Democratic Senators Seek SEC Investigation Into Trump Media’s Premium
Jul 29, 2026 by
CPI
Publicis Challenges Naming in India Antitrust Investigation Before Delhi Court
Jul 29, 2026 by
CPI
Appeals Court Revives AI Hotel Pricing Antitrust Lawsuit Against Caesars, MGM
Jul 29, 2026 by
CPI
EU Warns FIFA Commercial Overhaul Could Violate Competition Law
Jul 29, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes